Structure |
Chemical Name |
CAS |
MF |
|
Aprepitant Impurity 16 |
850354-60-8 |
|
|
Aprepitant Impurity 35 |
|
|
|
tert-butyl (3S,5R)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- (phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
|
C37H43FN2O5 |
|
Aprepitant iMpurity 40 |
|
|
|
Aprepitant iMpurity43 |
|
|
|
(3R,5R)-7-(2-(2-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid |
2243639-98-5 |
C33H37CaFN2O5 |
|
2-(4-Fluorophenyl)-δ-hydroxy-5-(1-methylethyl)-β-oxo-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid 1,1-Dimethylethyl Ester |
947262-20-6 |
C37H41FN2O5 |
|
アトルバスタチン環(huán)狀(フルオロフェニル)ナトリウム塩不純物 |
1315629-79-8 |
C33H34FN2NaO7 |
|
(2S,3R)-2-[(1S)-1-[3,5-ビス(トリフルオロメチル)フェニル]エトキシ]-3-(4-フルオロフェニル)モルホリン |
327623-37-0 |
C20H18F7NO2 |
|
(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(phenyl)Morpholine hydrochloride |
874460-46-5 |
C20H20ClF6NO2 |
|
Aprepitant iMpurity B |
|
|
|
Aprepitant Impurity 2 |
|
|
|
5-Methylarabinosylcytosine |
6829-31-8 |
C10H15N3O5 |
|
Aprepitant Impurity 24 |
|
|
|
Aprepitant |
1242175-38-7 |
C20H18F7NO2 |
|
Aprepitant Impurity 32 |
|
|
|
Aprepitant Impurity 42 |
172678-47-6 |
C20H18F7NO2 |
|
Nsc249004 |
7428-39-9 |
C9H13N3O5 |
|
Atorvastatin Cyclic Isopropyl Impurity |
873950-17-5 |
C33H35FN2O7 |
|
Difluoro Atorvastatin |
693794-20-6 |
C66H66CaF4N4O10 |
|
(3R,5S)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid |
|
C33H35FN2O5 |
|
(1R,2S,3S)-Aprepitant |
172822-28-5 |
C23H21F7N4O3 |
|
2-((4R,6R)-6-(2-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)ethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |
929540-41-0 |
C36H41CaFN2O5 |
|
(S,E)-7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-5-hydroxyhept-2-enoic acid calcium(II) |
1659317-57-3 |
C33H35CaFN2O4 |
|
4-(オキシラニルメトキシ)ベンゼンアセトアミド |
29122-69-8 |
C11H13NO3 |
|
1,3-Dioxane-4-acetic acid, 6-[2-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-, sodium salt (1:1), (4R,6R)- |
862260-38-6 |
C36H40FN2NaO5 |
|
Aprepitant iMpurity |
96730-04-0 |
C13H22NO4P |
|
Aprepitant Impurity 17 |
1333998-27-8 |
C20H19ClF7NO2 |
|
2-(4'-chloro-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-yl)-3-hydroxynaphthalene-1,4-dione |
1809464-27-4 |
C22H17ClO3 |
|
Aprepitant impurity C |
|
|
|
C-Desmethyl Atenolol |
1797116-92-7 |
C13H20N2O3 |
|
2-[4-(2,3-DIHYDROXYPROPOXY)PHENYL]ACETAMIDE |
61698-76-8 |
C11H15NO4 |
|
1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, 1,1-dimethylethyl ester, (βS,δR)- |
2588261-38-3 |
C37H43FN2O5 |
|
4-アセトキシイソフタル酸 |
5985-26-2 |
C10H8O6 |
|
(S)-2-((R)-1-(3,5-bis(trifluoroMethyl)phenyl)ethoxy)-4-benzylMorpholin-3-one |
327623-36-9 |
C21H19F6NO3 |
|
1-[2-[[(2R)-テトラヒドロ-4β-ヒドロキシ-6-オキソ-2H-ピラン]-2α-イル]エチル]-5-(4-フルオロフェニル)-2-イソプロピル-4,N-ジフェニル-1H-ピロール-3-カルボアミド |
125995-03-1 |
C33H33FN2O4 |
|
Aprepitant |
170902-80-4 |
C20H18F7NO2 |
|
Aprepitant Impurity 33 |
502537-39-5 |
C20H20F7NO3 |
|
Cytarabine Impurity 10 |
32830-01-6 |
C9H11N3O4 |
|
Aprepitant Impurity 44 |
172676-88-9 |
C23H21F7N4O3 |
|
Aprepitant iMpurity 37 |
|
|
|
(2Z)-2,3-Dehydroxy Atorvastatin (>90% Z) |
1191901-60-6 |
C33H33FN2O4 |
|
[2R-[2aR*),3a]-2-[1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine |
170729-79-0 |
C20H18F7NO2 |
|
Atorvastatin Lactam Impurity |
906552-18-9 |
C33H35FN2O6 |
|
2-(5-Benzyl-3,6-dioxopiperazin-2-yl)acetic Acid
(Diketopiperazine) |
|
C29H42N8O18S4 |
|
(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole |
65576-39-8 |
C17H17NO |
|
(1R,2S,3R)-Aprepitant |
1185502-97-9 |
C23H21F7N4O3 |
|
Aprepitant Impurity 22 |
934540-48-4 |
C20H16F7NO2 |
|
Aprepitant Impurity 9 |
219821-37-1 |
C24H25F7N4O4 |
|
Aprepitant Impurity 28 |
|
|
|
(3S,5S)-tert-butyl 7-(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
1428118-12-0 |
C37H43FN2O5 |
|
Aprepitant Impurity 53 |
|
|
|
亜りん酸トリベンジル |
15205-57-9 |
C21H21O3P |
|
1-(2-O,3-O,5-O-トリアセチル-β-D-アラビノフラノシル)-2,4(1H,3H)-ピリミジンジオン |
14057-18-2 |
C15H18N2O9 |
|
Atorvastatin Oxirane Impurity |
1246818-88-1 |
C26H24FNO3 |
|
アトルバスタチン関連化合物B (3S,5R ISOMER, OR (3S,5R)-7-[3-(フェニルカルバモイル)-5-(4-フルオロフェニル)-2-イソプロピル-4-フェニル-1H-ピロール-1-イル]-3,5-ジヒドロキシヘプタン酸カ |
887196-25-0 |
C33H34CaFN2O5+ |
|
Reaxys ID: 3623864 |
129385-61-1 |
C17H10ClNO3 |
|
(1S,2S,3S)-Aprepitant |
1242175-40-1 |
C23H21F7N4O3 |
|
Aprepitant Impurity 3 |
|
|
|
Aprepitant Impurity 12 |
172673-23-3 |
C23H21F7N4O4 |
|
Aprepitant Impurity 18 |
|
|
|
Aprepitant Impurity 14 |
|
|
|
4-(3-クロロ-2-ヒドロキシプロポキシ)ベンゼンアセトアミド (ATENOLOL IMPURITY D) |
115538-83-5 |
C11H14ClNO3 |
|
(3S,5S)-Atorvastatin sodium salt |
501121-34-2 |
C33H35FN2O5 |
|
(3S,5S)-アトルバスタチンアセトニドTERT-ブチルチルエステル |
472967-95-6 |
C40H47FN2O5 |
|
Nsc529487 |
3310-47-2 |
C9H13N3O6 |
|
(2R,3R)-2-[(1S)-1-[3,5-Bis(trifluoroMethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride |
1333998-21-2 |
C20H19ClF7NO2 |
|
アトルバスタチンラクタムラクトン |
1795791-15-9 |
C33H31FN2O5 |
|
Aprepitant EP Impurity C |
2208275-99-2 |
C29H25F7N4O3 |
|
Atorvastatin 2-Fluoro t-Butyl Ester |
1099474-28-8 |
C40H47FN2O5 |
|
r-Cytidine |
13913-16-1 |
C9H13N3O5 |
|
Aprepitant Impurity 15 |
1447693-83-5 |
C20H19ClF7NO2 |
|
Aprepitant Impurity 34 |
|
|
|
Cytarabine Impurity 13 |
82855-62-7 |
C17H19N5O8 |
|
Aprepitant iMpurity 38 |
|
|
|
Aprepitant iMpurity 41 |
|
|
|
1H-Dibenz[e,g]indole-1-heptanoic acid, 9-fluoro-2,3-dihydro-β,δ-dihydroxy-3-(1-methylethyl)-2-oxo-3-[(phenylamino)carbonyl]-, (βR,δR)- |
1046533-62-3 |
C33H33FN2O6 |
|
4,4'-[[(1-メチルエチル)イミノ]ビス[(2-ヒドロキシ-3,1-プロパンジイル)オキシ]]ビス-ベンゼンアセトアミド (ATENOLOL IMPURITY F)アテノロール不純物F |
87619-83-8 |
C25H35N3O6 |
|
Aprepitant iMpurity A |
|
|
|
Atorvastatin LactaM Phenanthrene CalciuM Salt |
1046378-58-8 |
C33H35CaFN2O6 |
|
1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-hydroxy-pyrimidine-2,4-dione |
69321-95-5 |
C9H12N2O7 |
|
Aprepitant Impurity 23 |
|
|
|
(3R,5R)-tert-butyl 7-(2,3-bis(4-fluorophenyl)-5-isopropyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate |
2588261-40-7 |
C37H42F2N2O5 |
|
Aprepitant |
1242175-36-5 |
C20H18F7NO2 |
|
Cytarabine Impurity 10 |
84902-98-7 |
C4H6N2O3 |
|
3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(3-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one |
|
|
|
2-[4-[(2RS)-2-HYDROXY-3[(1-METHYLETHYL)AMINO]PROPOXY]PHENYL]ACETONITRILE |
29277-73-4 |
C14H20N2O2 |
|
4-メチル-3-[[1-オキソ-2-(プロピルアミノ)プロピル]アミノ]-2-チオフェンカルボン酸 |
114176-52-2 |
C12H18N2O3S |
|
10-trans-Atorvastatin Acetonide tert-Butyl Ester |
1105067-90-0 |
C40H47FN2O5 |
|
(4S,6R)-6-(Cyanomethyl)-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester |
186508-95-2 |
C14H23NO4 |
|
4,4'-(2-HYDROXY-1,3-PROPANDIYLDIOXY)BIS(2-PHENYLACETAMIDE) |
141650-31-9 |
C19H22N2O5 |
|
Articaine IMpurity F (Articaine Acid PropionaMide HCl) |
|
|
|
Aprepitant Impurity 6 |
170902-81-5 |
C23H21F7N4O3 |
|
(3S,5S)-Atorvastatin (sodium salt) |
1428118-38-0 |
C33H36FN2NaO5 |
|
Aprepitant Impurity 19 |
1333995-14-4 |
|
|
Aprepitant Impurity 15 |
|
|
|
Aprepitant iMpurity 45 |
|
|
|
3H-Oxireno[3,4]pyrrolo[2,1-b][1,3]oxazine-3-butanoic acid, 1b-(4-fluorophenyl)hexahydro-β,7-dihydroxy-7-(1-methylethyl)-1a-phenyl-7a-[(phenylamino)carbonyl]-, (βR,3R)- |
1193817-52-5 |
C33H35FN2O7 |
|
3-(((3R)-3-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-2-(4-fluorophenyl)-1,4-dioxan-2-ylamino)methyl)-1H-1,2,4-triazol-5(4H)-one |
|
|
|
rel-5-クロロ-2,3,3aα*,12bα*-テトラヒドロ-2-メチル-1H-ジベンゾ[2,3:6,7]オキセピノ[4,5-c]ピロール |
65621-78-5 |
C17H16ClNO |